A Hemoglobin - Annals of Internal Medicine, 2003 - Am Coll Physicians In the Diabetes Control and Complications Trial (DCCT) (1), individuals with no clinically evident
complications of type 1 diabetes or early microvascular complications were exposed to different
levels of glycemic control for an aver- age of 6.5 years. At the end of the trial, those in the ... Related articles
C Minerva - Minerva, 2004 - minerva-ebm.be Cette étude semble montrer qu'une dose quotidienne de 12,5 mg de paroxétine est efficace
et bien tolérée dans le traitement des bouffées de chaleur de la femme ménopausée. Vu la durée
de cette étude, limitée à six semaines d'observation, il n'existe pas de preuve de la ... Cited by 2 - Related articles - Cached - All 2 versions
B Minerva - Minerva, 2004 - minerva-ebm.be Uit deze studie blijkt dat paroxetine aan een dosis van 12,5 mg/dag werkzaam is en goed wordt
verdragen in de behandeling van warmteopwellingen bij menopauzale vrouwen. Aangezien
deze studie de patiënten slechts zes weken opvolgde, is het nog niet duidelijk of het ... Related articles - Cached - All 2 versions
V Stearns, KL Beebe, M Iyengar, E Dube - Intern Med, 2000 - minerva-ebm.be Achtergrond Warmteopwellingen zijn de meest frequente klacht bij menopauzale vrouwen. Deze
klachten kunnen jaren aanwezig zijn; bij 20% van de vrouwen duren ze zelfs vijftien jaar. Ongeveer
75% van de vrouwen in de me- nopauze heeft last van warmteopwellingen, en bij 20% ... Related articles - View as HTML - All 2 versions
RL Barbieri - jfponline.com By now, I am sure, you are quite familiar with the Women's Health Initiative (WHI), the hormone
replacement therapy (HRT) trial whose estrogen-progestin arm was discontinued when it became
clear that risks exceeded benefits. 1 Chances are you've been inundated with questions ... Related articles - Cached - All 3 versions
CMC Morris - Medscape Family Medicine/Primary Care, 2002 - Medscape In patients with a past history of breast cancer who have menopausal symptoms, what are optimal
choices for treatment? ... Response from Charlene McClure Morris, PA-C A 1980 graduate of
The George Washington University PA Program. Ms. Morris has been in primary care ... Related articles
NCI supplied Agent - IRB, 2005 - wfubmc.edu Principal Investigator: Name Michelle Naughton, PhD Address Division of Public Health Sciences
Department of Social Sciences and Health Policy, Wake Forest University School of Medicine
2000 W. 1st Street, Rm. 224 Winston-Salem, NC 27104 Telephone (336) 716-2918 Fax ... Related articles - View as HTML - All 2 versions
AJ Allen, S Hemrick-luecke, CR Sumner, OB Wallace - 2006 - freepatentsonline.com 1. Use of a selective norepinephrine reuptake inhibitor for the manufacture of a medicament
for the treatment of hot flashes or vasomotor symptoms, wherein said selective norepinephrine
reuptake inhibitor is a compound of formula (IH): wherein, X is OH, C1-C4 alkoxy, NH 2 or ... Related articles - All 2 versions
- ►remedies4.com [PDF] WCH Flashes - Principles and practice of palliative care and …, 2006 - books.google.com CHAPTER 10• HOT FLASHES DOMINGO G. PEREZ AND CHARLES L. LOPRINZI Nearly three
fourth of menopausal women experience hot flashes (1), which are usually described as a sudden
and dis- turbing sensation of intense warmth that starts in the chest and then progresses ... Related articles - All 6 versions
